Collectively here, the Phase 1 maintenance trial offers a lot more than originally met the ear
[1] [2] These medications work by mimicking the action of naturally occurring GLP-1 hormones, which regulate appetite, slow gastric emptying, and influence insulin secretion
"Following a petition submitted by Danone, the FDA issued a qualified health claim for yogurt, recognizing a potential link between its regular consumption and a reduced risk of type 2 diabetes, giving consumers yet another compelling reason to shop the yogurt aisle," he states
Mounjaro and Zepbound warn about this explicitly on their labels, but Ozempic and Wegovy only warn more broadly about absorption of any drugs taken by mouth
Now, some GLP1s are approved specifically for weight loss in people without diabetes